BiochemProbe — Life Science Research Reagents

GSK-3484862 free base · Synonyms: GSK 3484862 · GSK3484862

GSK-3484862 is a non-covalent inhibitor.

For research use only. Not for human or veterinary use.

Research area Cancer
Purity >98% Stock Inquire

GSK-3484862 structure

CAS No.: 2170136-65-7

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
100 mg USD 550.00 BP-01346-100mg In stock Get quote
250 mg USD 900.00 BP-01346-250mg In stock Get quote
500 mg USD 1,250.00 BP-01346-500mg Inquire Get quote
1 g USD 1,850.00 BP-01346-1g In stock Get quote
5 g Inquire BP-01346-5g In stock Inquire
10 g Inquire BP-01346-10g In stock Inquire

Need another size or custom synthesis? Request a quote.

Description

GSK-3484862 is a non-covalent inhibitor for DNA methyltransferase (Dnmt1). GSK-3484862 induces DNA hypomethylation to against cancer. GSK-3484862 mediates dramatic demethylation in murine embryonic stem cells with minimal non-specific toxicity.

Biological activity

GSK-3484862 is a non-covalent inhibitor for Dnmt1. GSK-3484862 induces DNA hypomethylation to against cancer. GSK-3484862 mediates global demethylation in murine embryonic stem cells.

Identifiers

SMILES
O=C(N)[C@H](SC1=NC(N(C)C)=C(C#N)C(CC)=C1C#N)C2=CC=CC=C2
InChIKey
KIEQQZZDWUNUQK-MRXNPFEDSA-N

Specifications

MW (average)
365.4520
Formula
C19H19N5OS
CAS No.
2170136-65-7
Physical state
Solid
Color
light yellow to yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder 4℃ 2 years; In solvent -20℃ 1 month;

Solubility

soluble in DMSO

In vitro
DMSO : 20 mg/mL

References

[1]. Azevedo Portilho N, et al. The DNMT1 inhibitor GSK-3484862 mediates global demethylation in murine embryonic stem cells. Epigenetics Chromatin. 2021;14(1):56. Published 2021 Dec 15.
[2]. Liu Y, et al. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma. Mol Cancer. 2024;23(1):104. Published 2024 May 16.
[3]. Zhuang X, et al. Aging limits stemness and tumorigenesis in the lung by reprogramming iron homeostasis[J]. BioRxiv, 2024: 2024.06. 23.600305.
[4]. Chen Q, et al. GSK-3484862, a DNMT1 degrader, promotes DNMT3B expression in lung cancer cells. NAR Cancer. 2025;7(2):zcaf018. Published 2025 May 27.

Same research area

Search Cancer

Recently viewed